PTK7 as a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients, and resistance to anthracycline drugs

Biomarkers predicting resistance to particular chemotherapy regimens could play a key role in optimally individualized treatment concepts. PTK7 (protein tyrosine kinase 7) belongs to the receptor tyrosine kinase family involved in several physiological, but also malignant, cell behaviors. Recent stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ataseven, Beyhan, Gunesch, Angela, Eiermann, Wolfgang, Kates, Ronald E, Högel, Bernhard, Knyazev, Pjotr, Ullrich, Axel, Harbeck, Nadia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199823/
https://www.ncbi.nlm.nih.gov/pubmed/25336969
http://dx.doi.org/10.2147/OTT.S62676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199823/
https://www.ncbi.nlm.nih.gov/pubmed/25336969
http://dx.doi.org/10.2147/OTT.S62676

Ejemplares similares